Insider · CIK 0001982638
Richard Marshak
Files at TLSI (TriSalus Life Sciences, Inc.). First filing May 21, 2025, latest Oct 7, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TLSI: TriSalus Life Sciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | TriSalus Life Sciences, Inc. | $1,427 325 shares | -0% | +74% from low-42% from high | |
| 36Weak | TriSalus Life Sciences, Inc. | $34k 6,597 shares | -9% | +44% from low-10% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | TLSI TriSalus Life Sciences, Inc. | SOpen-market sale Common Stock | -325 | $4.39 | $1,427 | 127,994 | 5 d ago |
| Nov 24, 2025 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Common Stock | +60,000 | $0.00 | $0 | 113,854 | Nov 25, 2025 |
| Nov 24, 2025 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +120,000 | $0.00 | $0 | 408,937 | Nov 25, 2025 |
| May 19, 2025 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Common Stock | +21,428 | $5.18 | $111k | 75,698 | May 21, 2025 |
| May 19, 2025 | TLSI TriSalus Life Sciences, Inc. | SOpen-market sale Common Stock | -6,597 | $5.18 | $34k | 69,101 | May 21, 2025 |
| Nov 14, 2024 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Common Stock | +6,875 | $0.00 | $0 | 34,126 | Nov 15, 2024 |
| Nov 14, 2024 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +41,250 | $0.00 | $0 | 41,250 | Nov 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.